O Presidente da República, João Lourenço, vai inaugurar, na quarta-feira, 20, o Centro de Ciência de Luanda (CCL) que resulta da reconversão da antiga Fábrica de Sabão, depois de concluídas as obras de requalificação.

A infra-estrutura tecnológica integra várias exposições interactivas, um planetário e um auditório com uma tela gigante para projecção de filmes e documentários com efeitos, avança o Portal do Governo, consultado hoje pelo JA Online.

Com objectivo de elevar a cultura científica da população, em geral, e de crianças e jovens, em particular, por via da popularização do conhecimento científico e tecnológico, o CCL vai, após a inauguração pelo Presidente da República, implementar uma fase de promoção do funcionamento. 

Neste sentido, durante cinco semanas algumas instituições convidadas visitarão gratuitamente as exposições do Centro de Ciência de Luanda em grupos de até 30 indivíduos cada. 

A recepção dos visitantes, previamente convidados e agendados, deverá ocorrer durante todo o mês de Janeiro de 2024.

Em Fevereiro de 2024, o CCL inicia o regime normal de funcionamento com acesso às exposições e demais atracções mediante a compra de bilhetes.

47 thoughts on “PRESIDENTE JOÃO LOURENÇO INAUGURA CENTRO DE CIÊNCIA DE LUANDA”
  1. Ipamorelin + CJC 1295 Stack: The Dynamic Duo

    Ipamorelin + CJC 1295 Stack: The Dynamic Duo

    The combination of Ipamorelin and CJC‑1295 is often referred to as the “dynamic duo” in peptide therapy circles.

    Both peptides act on growth hormone pathways but with distinct mechanisms that
    complement each other, leading to amplified benefits
    for muscle gain, fat loss, recovery, and overall health.

    The stack’s popularity stems from its synergistic effects, minimal
    side‑effects compared to traditional HGH therapy,
    and a growing body of user testimonials and preliminary
    scientific data supporting its efficacy.

    Key Takeaways

    Ipamorelin is a selective growth hormone secretagogue that stimulates natural GH release with high specificity for the ghrelin receptor.

    CJC‑1295 is a long‑acting analog of GHRH (growth hormone‑releasing hormone) that prolongs GH secretion over 24–48 hours.

    Together they produce sustained increases in IGF‑1,
    improving protein synthesis, lipolysis, and tissue repair.

    The stack can be used for fat loss, muscle hypertrophy, improved recovery, anti‑aging benefits, and enhanced
    athletic performance.

    Proper dosing, timing, and monitoring are essential
    to avoid side effects such as water retention or increased appetite.

    What is Ipamorelin?

    Ipamorelin is a pentapeptide (His–Trp–Leu–Phe–Gly) that mimics the natural hormone ghrelin. It binds
    selectively to the GHS‑R1a receptor on pituitary cells, triggering
    the release of growth hormone without significant stimulation of cortisol
    or prolactin. Unlike other secretagogues such as GHRPs (growth hormone‑releasing peptides), Ipamorelin’s action is
    highly specific and exhibits a lower risk of adverse hormonal side effects.

    Ipamorelin Overview

    Chemical Structure: A short peptide chain that resists rapid enzymatic degradation, allowing it
    to remain active in circulation for several hours.

    Pharmacodynamics: Stimulates GH secretion via ghrelin receptor activation; increases IGF‑1 production in the
    liver.

    Clinical Uses: Investigated for growth hormone deficiency,
    muscle wasting disorders, and aging-related decline in GH levels.

    Administration: Typically subcutaneous injections, 10–20 µg per dose, twice daily or once daily depending on protocol.

    What is CJC 1295?

    CJC‑1295 (also known as Dalotide) is a synthetic analog of GHRH with an added peptide linker that prevents rapid clearance by the kidneys.
    This modification extends its half‑life to approximately 48 hours, allowing for
    once‑daily dosing while maintaining elevated GH levels.

    CJC-1295 Overview

    Chemical Modification: A cyclized structure with a carboxylated side chain that increases stability.

    Mechanism of Action: Binds GHRH receptors on the pituitary, leading to sustained
    release of GH and IGF‑1.

    Benefits: Supports muscle growth, fat loss, improved sleep architecture, and potential anti‑aging
    effects.

    Safety Profile: Generally well tolerated; however, high doses
    may cause transient increases in appetite or mild edema.

    How Does Ipamorelin + CJC 1295 Stack Work Together?

    Ipamorelin triggers a rapid surge of GH release each time it binds the ghrelin receptor, while CJC‑1295
    provides a steady background level of GH secretion. The combination ensures both peak and
    trough GH levels are maintained within an optimal range. This
    dual action leads to:

    Enhanced IGF‑1 synthesis over 24–48 hours.

    More efficient protein synthesis pathways in muscle cells.

    Greater activation of lipolytic enzymes for fat breakdown.

    Ipamorelin and CJC 1295 Stack for Fat Loss

    The sustained increase in GH and IGF‑1 promotes a metabolic shift
    toward catabolism of adipose tissue. Users often report:

    Reduced visceral fat accumulation.

    Improved resting metabolic rate.

    Lowered insulin levels, aiding in better glucose control.

    Ipamorelin and CJC 1295 Stack for Muscle Mass

    Muscle hypertrophy is driven by increased protein synthesis, satellite cell activation, and reduced muscle breakdown. The stack’s
    effects include:

    Faster recovery from intense training sessions.

    Increased lean body mass without significant water retention.

    Improved endurance and strength gains over time.

    Ipamorelin and CJC 1295 Dosage

    Typical dosing regimens vary by individual goals but generally follow these patterns:

    Peptide Standard Dose Frequency

    Ipamorelin 10–20 µg per injection 2× daily (morning & evening) or once nightly

    CJC‑1295 200–300 µg per injection Once daily, often in the morning

    Cycle Length: Most users cycle for 8–12 weeks followed by a
    washout period.

    Titration: Start at lower doses to assess tolerance;
    gradually increase based on response and side effect profile.

    Ipamorelin and CJC 1295 Benefits

    Muscle Gain: Accelerated hypertrophy, improved strength.

    Fat Reduction: Targeted visceral fat loss.

    Recovery: Faster muscle repair, reduced DOMS (delayed onset muscle soreness).

    Sleep Quality: Enhanced deep sleep stages due to GH’s role in sleep regulation.

    Anti‑Aging: Increased collagen production, improved skin elasticity, and overall vitality.

    Ipamorelin and CJC 1295 Side Effects

    Common side effects are mild and usually transient:

    Water retention or edema (rare).

    Mild headaches or dizziness during initial doses.

    Increased appetite due to GH’s influence on hunger hormones.

    Injection site reactions: redness, itching, or mild swelling.

    Long‑term safety data is limited; therefore, periodic
    monitoring of IGF‑1 and liver enzymes is recommended
    for users on extended cycles.

    Is ipamorelin side effects men and CJC 1295
    Legal?

    In many countries, these peptides are classified as prescription-only substances
    used for medical indications such as growth hormone deficiency.
    They are not approved by the FDA for performance enhancement or anti‑aging
    use. Possession or sale without a valid prescription may be illegal in certain jurisdictions.

    Athletes should consult anti‑doping regulations, as both peptides are banned by most sports governing bodies.

    Who Should Use Ipamorelin and CJC 1295?

    Ideal candidates include:

    Individuals with diagnosed GH deficiency or
    low IGF‑1 levels.

    Older adults seeking to mitigate age‑related muscle loss
    (sarcopenia).

    Athletes aiming for improved recovery and lean mass gains, provided
    they comply with anti‑doping rules.

    Those who have tried conventional supplements but seek a more
    targeted hormonal approach.

    Ipamorelin/CJC 1295 vs. Other Compounds

    When compared to other peptide stacks:

    vs. Sermorelin: CJC‑1295 offers longer duration and higher IGF‑1 levels; Sermorelin is shorter‑acting with fewer side effects.

    vs. Tesamorelin: Both increase GH, but Tesamorelin specifically targets visceral fat reduction in HIV patients; Ipamorelin/CJC 1295 provides broader anabolic benefits.

    vs. HGH (Human Growth Hormone): Peptide stacks stimulate natural GH production with less risk of supraphysiological levels and
    associated side effects such as gynecomastia or joint pain.

    Conclusion: Are Ipamorelin and CJC‑1295 Worth It?

    For those willing to navigate the legal and regulatory
    landscape, the Ipamorelin + CJC‑1295 stack offers a compelling alternative to direct HGH therapy.
    Its dual mechanism delivers sustained hormonal support with
    fewer side effects, making it attractive for bodybuilders, older adults,
    and health enthusiasts seeking natural anabolic stimulation. However,
    users should approach with caution: start at low doses, monitor
    physiological markers, and adhere to local laws.

    FAQs

    What are Ipamorelin and CJC‑1295 used for?

    They are employed to stimulate endogenous growth hormone release, aiding
    muscle growth, fat loss, recovery, and anti‑aging benefits.

    Are Ipamorelin and CJC‑1295 legal?

    In many regions they require a prescription; possession without medical authorization may be illegal.

    How are Ipamorelin and CJC‑1295 administered?

    Subcutaneous injections, typically 10–20 µg for Ipamorelin and 200–300 µg for CJC‑1295, once
    or twice daily.

    What are the potential benefits?

    Enhanced muscle hypertrophy, accelerated fat loss,
    improved recovery, better sleep, and anti‑aging effects.

    What are the potential side effects?

    Mild water retention, headaches, increased appetite, injection site reactions;
    rare cases of edema or dizziness.

    Comments and questions?

    Readers are encouraged to share experiences or ask for clarification on dosing protocols, monitoring strategies, or legal considerations in their region.

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *

Você não pode copiar o conteúdo desta página